LifeMD Investors Alert: Class Action Lawsuit Opportunity Awaits

Class Action Lawsuit Opportunity for LifeMD Investors

In a significant development for investors in LifeMD, Inc. (NASDAQ: LFMD), the Rosen Law Firm has announced an opportunity for those who purchased securities of LifeMD between May 7, 2025, and August 5, 2025, to lead a class action lawsuit regarding alleged securities fraud. As an investor, this could be a chance to seek compensation without upfront costs through a contingency fee arrangement, meaning that payment for legal services is only made if the case is won.

Important Deadlines

The Rosen Law Firm is reminding all purchasers of LifeMD securities during the specified period about the urgency of the situation, as the lead plaintiff deadline is set for October 27, 2025. Those who wish to take on the role of lead plaintiff must file with the court by this date, which entails being a representative party directing the litigation on behalf of other members in the class.

Steps to Take

Investors interested in joining the class action can do so by visiting Rosen Legal's submission form or can reach out directly by calling Phillip Kim, Esq. at 866-767-3653. The law firm emphasizes the importance of selecting qualified counsel, especially when navigating complex securities litigation.

Background of Allegations

The lawsuit poses serious allegations against LifeMD, claiming that defendants made materially false statements and omitted critical information during the class period. Key points from the case focus on allegations that:
1. LifeMD over-exaggerated its competitive position in the market.
2. The forecast for 2025 showed recklessness, failing to consider the rising costs of customer acquisition in LifeMD's RexMD segment.
3. Statements about LifeMD’s operational health, business direction, and economic prospects lacked a factual basis, leading to misleading representations to investors.

The lawsuit claims that when the true circumstances became apparent, significant financial damages were suffered by the investors, bringing forth the class action in a bid for restitution.

Rosen Law Firm’s Track Record

Rosen Law Firm has made a name for itself in investor rights advocacy. Over the years, they have achieved several notable settlements in securities class actions and are recognized for their dedication and successful track record in representing investors. In 2019, the firm secured over $438 million for investors, and they continue to rank highly in the area of class action securities litigation.

Investors are urged to stay informed on developments related to the case and to ensure their participation aligns with the set deadlines. This class action represents a vital avenue for justice for those impacted by the alleged securities fraud at LifeMD.

Stay Connected

For updates and further information, investors can follow Rosen Law Firm on LinkedIn, Twitter, and Facebook. Engaging with these platforms can offer useful insights into class actions like the one against LifeMD, as well as the ongoing advocacy for investors' rights.

In conclusion, if you are an investor who purchased LifeMD securities during the said period, now is the time to act. Don’t miss the chance to take part in this important class action and seek the compensation you deserve.

For additional inquiries and details regarding participation, again, consider reaching out to Phillip Kim, Esq., or visiting the Rosen Law Firm website.